SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021456
Filing Date
2018-08-13
Accepted
2018-08-13 16:02:43
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fixx-10q_20180630.htm 10-Q 2038584
2 EX-31.1 fixx-ex311_7.htm EX-31.1 16543
3 EX-31.2 fixx-ex312_9.htm EX-31.2 18429
4 EX-32.1 fixx-ex321_6.htm EX-32.1 9710
5 EX-32.2 fixx-ex322_8.htm EX-32.2 9928
  Complete submission text file 0001564590-18-021456.txt   6992637

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fixx-20180630.xml EX-101.INS 1580723
7 XBRL TAXONOMY EXTENSION SCHEMA fixx-20180630.xsd EX-101.SCH 47526
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fixx-20180630_cal.xml EX-101.CAL 40003
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fixx-20180630_def.xml EX-101.DEF 166002
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20180630_lab.xml EX-101.LAB 348542
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20180630_pre.xml EX-101.PRE 263868
Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 181012248
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences